SCHEMBL9938968

SCHEMBL9938968

CCCC(=O)NCc1ccc(CNC(=O)CCC)nn1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.51
CYP2C19 P33261 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
HPGD P15428 5/20 0.44
EPHX2 P34913 1/20 0.44
ALDH1A1 P00352 1/20 0.44
TP53 P04637 1/20 0.43
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
GAA P10253 1/20 0.42
ALOX15 P16050 1/20 0.42
CASP1 P29466 1/20 0.42
KMT2A Q03164 1/20 0.42
HSD17B10 Q99714 1/20 0.42
RECQL P46063 1/20 0.42
HTT P42858 1/20 0.41
CASP2 P42575 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14753609 0.83 CYP3A4 (0.51) CYP3A4CYP2C19L3MBTL1HPGDEPHX2
SCHEMBL1690435 0.78 HPGD (0.68) CYP3A4HPGDALDH1A1MEN1GAA
SCHEMBL28124071 0.76 NAMPT (0.50) CYP3A4CYP2C19L3MBTL1HPGDALDH1A1
SCHEMBL2092775 0.74 CYP3A4 (0.61) CYP3A4CYP2C19L3MBTL1HPGDEPHX2
SCHEMBL24324500 0.74 CYP3A4 (0.42) CYP3A4CYP2C19L3MBTL1HPGDALDH1A1
SCHEMBL5861280 0.74 HTT (0.47) CYP3A4CYP2C19L3MBTL1HPGDALDH1A1
SCHEMBL14753612 0.74 HDAC3 (0.46) CYP3A4CYP2C19L3MBTL1HPGDALDH1A1
SCHEMBL1690615 0.74 CYP3A4 (0.42) CYP3A4CYP2C19L3MBTL1HPGDALDH1A1
SCHEMBL18134836 0.73 CYP3A4 (0.65) CYP3A4CYP2C19L3MBTL1HPGDEPHX2
SCHEMBL770934 0.73 CYP3A4 (0.87) CYP3A4CYP2C19L3MBTL1HPGDEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10290819-B2 Metal complexes MERCK PATENT GMBH (DE) 2019-05-14 US disclosed
US-20130284977-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2013-10-31 US disclosed
WO-2012079741-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2012-06-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10290819-B2 Metal complexes PICALM, IMMT, IKZF3 CYP3A4 1870/4885CYP2C19 3782/4885L3MBTL1 3693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.